Skip to content
healthcare.dev

TOPIRAMATE

NDC 72865-314, Topiramate, tablet, from XLCare Pharmaceuticals, Inc..

Product NDC
72865-314
Status
Listed
Labeler
XLCare Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA215414
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72865-314 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TOPIRAMATE50 mg/1

Pharmacologic classes

Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
72865-314-10728650314101000 TABLET in 1 BOTTLE (72865-314-10)
72865-314-607286503146060 TABLET in 1 BOTTLE (72865-314-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/546103e1-ea6e-466b-b0de-b1ff8c494512

Use it

Look up 72865-314 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72865-314 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72865-314. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.